Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott)
- 1 November 2020
- journal article
- research article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 132, 104618
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertipPLOS ONE, 2020
- Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infectionClinical Microbiology and Infection, 2020
- Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization testJournal of Clinical Virology, 2020
- Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisationJournal of Clinical Virology, 2020
- Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)Journal of Clinical Virology, 2020
- Evaluation of the COVID-19 IgG/IgM Rapid Test from Orient Gene BiotechJournal of Clinical Microbiology, 2020
- Interpreting Diagnostic Tests for SARS-CoV-2JAMA, 2020
- Antibody responses to SARS-CoV-2 in patients with COVID-19Nature Medicine, 2020
- Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patientsEmerging Microbes & Infections, 2020